Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1RGR

Cyclic Peptides Targeting PDZ Domains of PSD-95: Structural Basis for Enhanced Affinity and Enzymatic Stability

Summary for 1RGR
Entry DOI10.2210/pdb1rgr/pdb
DescriptorPresynaptic density protein 95, postsynaptic protein CRIPT peptide, BETA-ALANINE (3 entities in total)
Functional Keywordspdz1 domain, structural protein-de novo protein complex, structural protein/de novo protein
Biological sourceRattus norvegicus (Norway rat)
More
Cellular locationCell membrane; Peripheral membrane protein: P31016
Total number of polymer chains2
Total formula weight11718.13
Authors
Piserchio, A.,Salinas, G.D.,Li, T.,Marshall, J.,Spaller, M.R.,Mierke, D.F. (deposition date: 2003-11-12, release date: 2004-05-18, Last modification date: 2024-10-30)
Primary citationPiserchio, A.,Salinas, G.D.,Li, T.,Marshall, J.,Spaller, M.R.,Mierke, D.F.
Targeting Specific PDZ Domains of PSD-95; Structural Basis for Enhanced Affinity and Enzymatic Stability of a Cyclic Peptide.
Chem.Biol., 11:469-473, 2004
Cited by
PubMed Abstract: A cyclic peptide, Tyr-Lys-c[-Lys-Thr-Glu(betaAla)-]-Val, incorporating a beta-Ala lactam side chain linker and designed to target the PDZ domains of the postsynaptic density protein 95 (PSD-95), has been synthesized and structurally characterized by NMR while free and bound to the PDZ1 domain of PSD-95. While bound, the lactam linker of the peptide makes a number of unique contacts outside the canonical PDZ binding motif, providing a novel target for PDZ-domain specificity as well as producing a 10-fold enhancement in binding affinity. Additionally, the cyclization greatly enhances the enzymatic stability, increasing the duration that the peptide inhibits the association between PSD-95 and glutamate receptors, effectively inhibiting the clustering of kainate receptors for over 14 hr after application. Highly specific regulation of kainate receptor action may provide a novel route for treatment of drug addiction and epilepsy.
PubMed: 15123241
DOI: 10.1016/j.chembiol.2004.03.013
PDB entries with the same primary citation
Experimental method
SOLUTION NMR
Structure validation

251174

PDB entries from 2026-03-25

PDB statisticsPDBj update infoContact PDBjnumon